advertisement
Cui QN 23
Showing records 1 to 23 | Display all abstracts from Cui QN108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Salowe RJ
BMJ open ophthalmology 2023; 8:
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Lawrence ECN
Frontiers in cellular neuroscience 2023; 17: 1156829
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Yue J
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Chen Y
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Khan RS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Guo M
Frontiers in cellular neuroscience 2023; 17: 1156829
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Zenebe-Gete S
BMJ open ophthalmology 2023; 8:
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Schwartz TD
Frontiers in cellular neuroscience 2023; 17: 1156829
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Duong TT; Dine KE
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Lee R
BMJ open ophthalmology 2023; 8:
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Wu J; Lu J
Frontiers in cellular neuroscience 2023; 17: 1156829
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Cui QN
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Gudiseva HV; Di Rosa I
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
O'Neill N
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Nikonov S; Sterling JK
Frontiers in cellular neuroscience 2023; 17: 1156829
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Ross AG
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Aravand P; Liu T
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108736 Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
Cui QN
Frontiers in cellular neuroscience 2023; 17: 1156829
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Cui QN; Miller-Ellis E
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Chaqour B; Shindler KS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Addis V; Sankar PS
BMJ open ophthalmology 2023; 8:
108155 Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure
Ross AG
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023; 20: 896-907
108706 Risk factors for structural and functional progression of primary open-angle glaucoma in an African ancestry cohort
Daniel E; Ying GS; O'Brien JM
BMJ open ophthalmology 2023; 8: